Steroid is First Drug Shown to Prevent Deaths from COVID-19
Nature Magazine, Vol 582, 25 June 2020, p. 469.

Source describing financial benefits of dexamethasone

Dexamethasone is a medical staple. It is in abundance in pharmacies worldwide; for a cost of less than \$63, 8 patients can be treated using dexamethasone.

Northwestern University

Google

Dexamethasone is a steroid evaluated for use in improving outcomes for COVID-19 patients through mitigating the inflammatory response during infection.

- 28-day mortality and other clinical outcomes in a randomized controlled trial of patients in the UK through the RECOVERY project
- Financial benefits 

Dexamethasone as a treatment for COVID -19

DEX usage reduced 28-day mortality for patients requiring mechanical ventilation and, to a lesser degree, patients receiving other oxygen therapy.

- Methods
- Results 
- Discussion


28-day mortality and other clinical outcomes in a randomized controlled trial of Dexamethasone (DEX) among hospitalized COVID-19 patients in the UK RECOVERY project

Learn Before

Related

Learn After